April 30, 2011 - New NAS member Angelika Amon of Koch Institute for Integrative Cancer Research presents her work at the NAS Annual Meeting. She investigates how the adverse effects of aneuploidy are overcome during tumor evolution and how it could be exploited for new tumor therapies.